MedPage Today on MSN
Once-Monthly GLP-1 Shot? Mangos for Blood Sugar Control; New Acromegaly Treatment
The investigational GLP-1 receptor agonist MET-097i, which may be able to be dosed just once a month, yielded weight loss of ...
Affordability and access drive "gray," says Sabina Hemmi, founder of GLP Winner, a consumer watchdog. Some microdose the at-home concoctions as a cost-effective maintenance regimen. Others use these ...
California [US], October 2 (ANI): Cancer cells are relentless in their drive to expand and divide, frequently reprogramming ...
Update: Sadly, this promotion has ended. Disney+ and Hulu rates are increasing in October 2025. Here’s how to lock in a lower monthly cost before the price hike. The best Disney+ offer of the year is ...
The 2025 NFL season continues this week with a Thursday Night Football match-up between the San Francisco 49ers and the L.A. Rams. The Minnesota Vikings will play the Cleveland Browns in London Sunday ...
OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a ...
A team of researchers at Karolinska Institutet, together with colleagues from Linköping University, has uncovered the ...
Endophilin A1 at postsynaptic sites promotes inhibitory postsynaptic organization through interaction with gephyrin to maintain E/I balance, which is essential for the suppression of epilepsy ...
3don MSN
Protein engineering toolset boosts efficacy of CAR-T cells targeting blood and solid cancers
Cancer researchers focused on improving the success of cancer immunotherapies introduced a new tool in a Yale study published ...
The trial enrolled patients with unresectable metastatic melanoma who had at least 1 prior line of therapy that had to have the anti–PD-1 therapy backbone. They could or could not have had a BRAF ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback